Skip to content

Zymeworks ZYME Lease Liability Payments - Due After Year Five

Lease Liability Payments - Due After Year Five at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$24.63M

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's lease liability payments - due after year five.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's lease liability payments - due after year five?
Zymeworks (ZYME) reported lease liability payments - due after year five of $2.22M in Q1 2026.
How has Zymeworks's lease liability payments - due after year five changed year-over-year?
Zymeworks's lease liability payments - due after year five decreased by 53.1% year-over-year, from $4.73M to $2.22M.
What does lease liability payments - due after year five mean?
Represents the total undiscounted future cash outflows required for operating and finance lease obligations beyond a five-year horizon. This metric provides visibility into long-term fixed occupancy and equipment costs, which are critical for assessing structural overhead and long-term solvency.